Training activity information
Details
Using representative patient samples from a range of tissue types, with a consultant supervisor identify the following processes:
- Metaplasia
- Dysplasia
- Malignancy
- Metastasis
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Role of the patient history in developing the clinical picture
- Implications for patient pathways
- Differences between the types of pathological processes
- Macroscopic vs microscopic identification
- Microscopical differences between normal tissue morphology and tissue undergoing these processes
- Local SOPs
- Specimen block sampling and macroscopic description
- Quality of blocks
- RCPath tissue pathways and cancer datasets
- Screening programmes
- Selection of histochemical, immunohistochemical, and molecular techniques to demonstrate different cell types involved these pathological processes
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What are the key histological features that differentiate metaplasia, dysplasia, malignancy, and metastasis?
- What resources (e.g., textbooks, online materials, previous case notes) can you review beforehand to refresh your understanding?
- What are the expected safety procedures when handling patient samples and using microscopes?
- What level of consultant supervision will be provided?
- What is the process for asking questions or seeking guidance during the activity?
- Consider the specific insights you hope to gain from engaging with the activity. Do you want to improve your ability to recognise subtle histological changes indicative of these processes?
- Are you aiming to understand the progression from dysplasia to malignancy better?
- Do you want to learn more about the patterns of metastasis in different tissue types?
- Think about what you already know about these pathological processes. What are your current strengths and weaknesses in identifying these features microscopically?
- What types of tissue samples might be used?
- Are there any specific cases or examples you might review beforehand?
- Consider possible challenges you might face during the activity, and think about how you might handle them. For example, what if the histological features are not clear-cut? How will you approach cases with overlapping or ambiguous features?
In action
- Pay attention to your actions. How are you approaching the task of examining the histological slides?
- What magnification are you starting with, and why?
- What features are you initially focusing on?
- What decisions are you making as the activity progresses?
- Are you moving to different areas of the slide?
- Are you comparing different tissue components?
- Are you seeking the consultant supervisor’s opinion at certain points?
- Why are you making these decisions?
- What aspects of your practice feel intuitive, and what requires more conscious effort?
- Are you immediately recognising certain cellular patterns, or are you having to actively think through the characteristics of metaplasia, dysplasia, malignancy, and metastasis?
- How effective are your actions in identifying the required pathological processes?
- Are you confidently identifying examples of metaplasia, dysplasia, malignancy, and metastasis?
- Are you finding examples of each?
- What challenges are you facing during this activity?
- Are the histological features subtle or ambiguous?
- Are you struggling to differentiate between certain processes?
- Are there artefacts on the slides that are making interpretation difficult?
- What can you learn from this activity as it unfolds?
- Are you noticing new histological features or patterns that you hadn’t appreciated before?
- Is the consultant supervisor highlighting specific aspects or providing insights that are enhancing your understanding?
- How does this activity connect to your existing knowledge and skills?
- Are you drawing upon your understanding of normal histology and basic pathological principles?
- Are you linking these microscopic findings to the potential clinical significance of these processes?
- Are there alternative approaches you could be considering? If you are struggling to identify a specific process, could you try focusing on different cellular or architectural features?
- Could you compare the current slide with previous examples you have seen?
- What support or guidance might you need in this moment?
- Are there specific areas where you would benefit from the consultant supervisor’s expertise?
- What questions do you need to ask to clarify your understanding or confirm your observations?
- Are you working within your scope of practice?
- Are you attempting to make definitive diagnoses independently, or are you appropriately seeking and valuing the consultant supervisor’s input for identification and interpretation?
On action
- Begin by summarising the key points of the experience. What specific tissue types did you examine?
- What examples of metaplasia, dysplasia, malignancy, and metastasis did you identify (or not identify)?
- What were the key histological features that helped you in this process?
- What was the role of the consultant supervisor in this activity?
- What skills or knowledge did you develop or improve through this activity?
- Did you enhance your ability to recognise the microscopic features of these different pathological processes?
- Did you improve your understanding of how these processes can co-exist or progress?
- Were there any unexpected challenges or successes during the activity?
- What did you learn from these?
- Did you find any particular process more difficult to identify than others?
- Were there any instances where your initial impression differed from the consultant’s opinion, and what did you learn from that discussion?
- Did you successfully identify all the required processes, and what contributed to your success?
- How important is the ability to accurately identify these processes in a diagnostic setting?
- How will this experience contribute to your future reporting skills and patient care?
- What areas for continued development have been identified as a result of this activity?
- Do you need to spend more time reviewing the histological characteristics of a particular process?
- Do you need to seek further examples of these conditions?
- How can you apply the learning from this activity to your routine practice?
- Will you now approach the examination of histological slides with a more systematic or focused approach?
- Will you pay closer attention to specific architectural or cellular features?
- Identify the actions / ‘next steps’ you will now take to support the assimilation of what you have learned.
- Will you review relevant textbook chapters or online resources?
- Will you discuss challenging cases with colleagues?
- What support or resources might you need to further develop in the areas identified through this reflection?
- Would it be beneficial to review specific case examples with the consultant supervisor? Are there any online learning modules or workshops that could enhance your understanding?
Beyond action
- Since undertaking this DTA, have you encountered similar cases?
- How does your understanding and confidence in identifying metaplasia, dysplasia, malignancy, and metastasis now compare to when you first completed this activity?
- Have you applied the techniques or insights gained from working with the consultant supervisor during this DTA in subsequent experiences?
- Can you identify specific ways your approach to assessing histological slides has been influenced?
- Looking back at your reflections on this DTA and other subsequent experiences, what overarching themes or areas for development have emerged regarding your understanding of abnormal proliferation?
- What further actions will you take to consolidate this learning, perhaps through further reading or seeking specific case examples?
- How has the experience of identifying these key pathological processes under supervision contributed to your ability to describe and interpret similar findings in other contexts, such as when contributing to case discussions or drafting reports?
- Did the interaction with the consultant enhance your communication skills when discussing complex cases?
- Can you recall specific instances where your understanding gained from this DTA helped you in interpreting a slide or understanding a diagnostic challenge?
- How has your confidence in recognising these features grown over time?
- Identify the transferable skills you are developing through these training activities. Beyond the specific identification of these pathological processes, what broader skills were developed, such as attention to detail, critical thinking, and the ability to learn from expert feedback?
- How will these skills benefit you in future, more complex diagnostic scenarios?
- Identify clear actions for continued development of the skills introduced through these activities. What ongoing learning strategies will you employ to continue refining your ability to identify and interpret these significant histological findings as you progress in your career?
- Will you actively seek out challenging cases or attend relevant educational sessions?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 6 |
Outcome
Use histological techniques to demonstrate the different types of abnormal proliferation. |
| # 9 |
Outcome
Practice safely in accordance with quality management and accreditation standards. |